Astellas Pharma Inc. (ALPMF) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Astellas Pharma Inc.

    OTC: ALPMF · Real-Time Price · USD
    11.10
    0.00 (0.00%)
    At close: Sep 26, 2025, 9:32 AM

    Astellas Pharma Balance Sheet Statement

    Financials in JPY. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Cash & Equivalents
    		 188.37B 335.69B 376.84B 315.99B 326.13B
    Short-Term Investments
    		 29.94B 28.78B 19.78B 21.3B 5.56B
    Long-Term Investments
    		 18.99B 163.02B 145.03B 141.21B 146.8B
    Other Long-Term Assets
    		 153.25B 45.59B 1M -1M -1M
    Receivables
    		 632.52B 534.99B 427.96B 382.46B 343.18B
    Inventory
    		 297.26B 248.74B 174.39B 153.07B 164.08B
    Other Current Assets
    		 53.25B 46.54B 70.76B 71.83B 39.2B
    Total Current Assets
    		 1,201.3B 1,194.7B 1,050B 923.35B 872.59B
    Property-Plant & Equipment
    		 328.92B 293.74B 286.46B 269.04B 264.62B
    Goodwill & Intangibles
    		 1,538.9B 1,872.5B 890.91B 926.46B 935.44B
    Total Long-Term Assets
    		 2,138.2B 2,374.9B 1,406.6B 1,409B 1,401B
    Total Assets
    		 3,339.5B 3,569.6B 2,456.5B 2,332.4B 2,273.6B
    Account Payables
    		 187.84B 185.19B 140.24B 130.74B 124.78B
    Deferred Revenue
    		 n/a n/a -88.55B -157.73B -136.1B
    Short-Term Debt
    		 266.53B 472.28B 75B n/a 120B
    Other Current Liabilities
    		 572.69B 458.08B 366.98B 420.12B 222.7B
    Total Current Liabilities
    		 1,061.6B 1,285.7B 726.03B 687.41B 592.37B
    Long-Term Debt
    		 564.89B 447.74B 50B n/a 80.4B
    Other Long-Term Liabilities
    		 194.43B 240.15B 51.25B 45.73B 50.94B
    Total Long-Term Liabilities
    		 764.68B 687.89B 222.53B 184.68B 295.14B
    Total Liabilities
    		 1,826.3B 1,973.6B 948.56B 872.09B 887.51B
    Total Debt
    		 831.43B 1,005.7B 200.01B 212.74B 278.26B
    Book Value
    		 1,513.3B 1,596B 1,508B 1,460.3B 1,386.1B
    Book Value Per Share
    		 842.11 889.98 828.54 789.48 746.38
    Common Stock
    		 103B 103B 103B 103B 103B
    Retained Earnings
    		 740.94B 809.4B 908.16B 944.26B 953.29B
    Comprehensive Income
    		 n/a n/a 340.64B 247.51B 167.37B
    Shareholders Equity
    		 1,513.3B 1,596B 1,508B 1,460.3B 1,386.1B
    Total Investments
    		 18.99B 124.38B 110.58B 101.88B 102.97B

    Add to Watchlist